Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

NEW WAY OF LOOKING AT PEDIATRIC INFECTIOUS DISEASES

1/22/2009

- Interview with Jean-Laurent Casanova, M.D., Ph.D., Professor of Medicine, Head of the Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University and Editor in Chief of a new peer-reviewed journal, Inborn Errors of Immunity

Dr. Casanova studies the genetics of human predisposition to pediatric infectious diseases, particularly mycobacterial diseases, invasive pneumococcal diseases, and herpes simplex encephalitis. He is interested in identifying Mendelian "holes" in the immune defense of otherwise healthy children who are susceptible to specific infectious diseases, work that has resulted in a paradigm shift in human clinical medicine and fundamental immunology.


Dr. Casanova's laboratory aims to understand what it is that makes some children develop a severe clinical illness in the course of infection while others exposed to the same microbe remain unharmed. In the past decade, the Casanova and Abel laboratory in Paris revealed that single genetic lesions in children confer severe and selective vulnerability to certain illnesses, whereas corresponding infections in adults result more from polygenetic inheritance. This work not only blurs the distinction between patient-based Mendelian genetics and population-based complex genetics but has also provided experimental support for a unified theory of human infectious diseases.


During this week's podcast, Dr. Casanova provides additional evidence that infectious diseases are also genetic, perhaps even more so than any other group of human disease, despite the prevailing view that infectious diseases are essentially environmental. He discusses his novel theory of primary immunodeficiencies and elaborates on the concept of Mendelian holes. Dr. Casanova also explains the profound clinical implications that result from the study of these Mendelian holes.
Dr. Casanova received his M.D. from the University of Paris René Descartes in 1987 and his Ph.D. in immunology from the University of Paris Pierre et Marie Curie in 1992, after being trained at the Pasteur Institute in Paris and the Ludwig Institute for Cancer Research in Lausanne. Following a residency in pediatrics in Paris, he completed a clinical fellowship in the pediatric immunology-hematology unit of the Necker Medical School in Paris. In 1999 he was appointed a professor of pediatrics at Necker, where, with Dr. Abel, he cofounded and codirected the Laboratory of Human Genetics of Infectious Diseases. He was appointed professor at Rockefeller University in 2008. Dr. Casanova was an international research scholar with the Howard Hughes Medical Institute from 2005 to 2008 and is a member of the European Molecular Biology Organization and the American Society for Clinical Investigation. Dr. Casanova is the recipient of the 2008 Richard Lounsbery Award from the French and American Academies of Sciences and a Professor Lucien Dautrebande Pathophysiology Foundation Prize from the Belgian Royal Academy of Medicine in 2004.

Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll